Physician profile
Reena Patel
NPI 1437847258
$721.03
in general payments reported to CMS, 2019-2025
14 companies · $236 in 2025
The $236 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $213 · 2024: $271 · 2025: $236.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $721.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $721.03 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sumitomo Pharma America, INC. | $136.35 | 2023-2025 | Myfembree |
| Mayne Pharma Commercial LLC | $120.81 | 2023-2025 | |
| Shield Therapeutics INC | $88.24 | 2024 | |
| Exeltis, USA INC. | $56.94 | 2023-2025 | Slynd |
| Ethicon US, LLC | $50.12 | 2025 | Echelon Flex |
| Organon LLC | $45.63 | 2023-2024 | Nexplanon |
| Millicent US INC | $42.49 | 2025 | Femring, Intrarosa |
| Pfizer INC. | $36.40 | 2023-2024 | |
| Merck Sharp & Dohme LLC | $34.16 | 2023-2024 | Gardasil 9, Gardasil |
| Abbvie INC. | $28.31 | 2023 | |
| Davol INC. | $23.68 | 2024 | Arista Ah Flexitip |
| Astellas Pharma US INC | $22.35 | 2024 | Veozah |
| Minerva Surgical, INC | $18.40 | 2024 | |
| Coopersurgical, INC. | $17.15 | 2025 | Paragard T 380a |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Reena Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.